Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Some gonadal hormone drugs can block filovirus entry into cells.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.